UnitedHealth Group Inc. (UNH) Shares Sold by Northern Capital Management LLC
Northern Capital Management LLC lowered its position in UnitedHealth Group Inc. (NYSE:UNH) by 21.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,875 shares of the healthcare conglomerate’s stock after selling 1,575 shares during the period. Northern Capital Management LLC’s holdings in UnitedHealth Group were worth $830,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of UNH. Tiemann Investment Advisors LLC raised its stake in UnitedHealth Group by 5.0% in the first quarter. Tiemann Investment Advisors LLC now owns 5,265 shares of the healthcare conglomerate’s stock worth $679,000 after buying an additional 250 shares during the period. Virginia Retirement System acquired a new position in shares of UnitedHealth Group during the first quarter worth about $42,348,000. Nisa Investment Advisors L.L.C. increased its position in shares of UnitedHealth Group by 0.5% in the first quarter. Nisa Investment Advisors L.L.C. now owns 374,592 shares of the healthcare conglomerate’s stock worth $48,285,000 after buying an additional 1,800 shares in the last quarter. Thomas White International Ltd. increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Thomas White International Ltd. now owns 17,228 shares of the healthcare conglomerate’s stock worth $2,220,000 after buying an additional 50 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. acquired a new position in shares of UnitedHealth Group during the first quarter worth about $2,702,000. Institutional investors and hedge funds own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.24% during midday trading on Tuesday, hitting $138.16. The company had a trading volume of 2,452,575 shares. The stock has a 50 day moving average price of $138.21 and a 200 day moving average price of $136.26. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The firm has a market capitalization of $131.58 billion, a P/E ratio of 21.62 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. On average, equities analysts anticipate that UnitedHealth Group Inc. will post $7.90 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were given a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date of this dividend was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
A number of research analysts have recently issued reports on UNH shares. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Credit Suisse Group AG reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, June 10th. Sanford C. Bernstein started coverage on UnitedHealth Group in a research note on Wednesday, June 15th. They issued an “outperform” rating and a $171.00 price objective on the stock. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, June 21st. Finally, Wolfe Research started coverage on UnitedHealth Group in a research note on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 price objective on the stock. One research analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.65% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.